| | | |

Physical Function Predicts Mesothelioma Surgery Outcomes

ByAlex Strauss

physical functionA patient’s level of physical function prior to mesothelioma surgery is a strong predictor of how well they will do after surgery.

That is the conclusion of a new University of Maryland study. Researchers analyzed the cases of 54 pleural mesothelioma patients before and after lung-sparing P/D surgery. 

The goal was to see what factors had the biggest impact on their post-surgical outcomes. Patients underwent lung function and physical function tests both before and after their operations. 

It turns out that a mesothelioma patient’s ability to be physically active is even more important than their lung function in predicting their recovery.

Lung-Sparing Pleural Mesothelioma Surgery

Pleural mesothelioma is a cancer of the multi-layer membrane (pleura) that surrounds the lungs. As tumors grow, they can constrict and invade the lungs. 

There are two main surgical approaches to pleural mesothelioma. One removes one of the lungs. The other, called pleurectomy with decortication (P/D), leaves the lungs intact. 

Mesothelioma is caused by exposure to asbestos. It can take decades to develop. Most people who receive a mesothelioma diagnosis are over 65. A person’s level of physical function at this age can vary widely. 

The Eastern Cooperative Oncology Group Performance Status (ECOG) test measures physical function in cancer patients. The higher a person scores on this test, the better they are able to perform everyday tasks. Not surprisingly, older patients tend to have lower ECOG scores.

Some lung function tests measure how much air the lungs can hold. Others measure the amount of air a person can exhale and how long it takes. A diffusing capacity test measures how easily oxygen enters the bloodstream.

The Link Between Physical Function and Mesothelioma Outcomes

The new study included 54 pleural mesothelioma patients who had operations between 2015 and 2020. The patients all had extended P/D/ surgery. Surgeons removed their diseased pleural lining and other tissues that could host new mesothelioma tumors. 

After surgery, many pleural mesothelioma patients end up on a ventilator. Some require a chest tube to drain fluid. Others may need to stay in the hospital for many days or weeks.

The goal of the new study was to see if pre-surgical physical function or lung function affected any of these things. 

Outcomes Linked to ECOG Scores

According to the researchers, a person’s ECOG score before surgery was the best predictor of postoperative physical function. 

“Preoperative ECOG was a significant predictor of postoperative patient outcomes while preoperative lung function lacked predictive ability,” writes lead author Simon Ho. A person’s age also played a role. Older patients tended to have more physical difficulties after surgery than younger ones. 

The study brings up two important questions: Could improving a patient’s physical function prior to mesothelioma surgery improve their outcomes? And do more patients need rehabilitation after mesothelioma surgery to improve physical function?

The research team says their study shows the importance of rehabilitation as soon as possible for the best mesothelioma surgery outcomes.

“Patients with MPM should receive rehabilitation early after diagnosis and throughout the continuum of care,” the study concludes. “The results of our study highlight…the need for early rehabilitation and further research to determine optimal rehabilitation interventions.”

Source: 

Ho, S, et al, “Examining the impact of physical function performance in predicting patient outcomes after lung-sparing surgery for malignant pleural mesothelioma”, August 29, 2021, Disability and Rehabilitation, Online ahead of print, https://www.tandfonline.com/doi/abs/10.1080/09638288.2021.1970256?journalCode=idre20

 

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    ByAlex Strauss

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    ByAlex Strauss

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…